Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Opinion|Videos|December 23, 2024

Navigating HER2 Heterogeneity: Precision Pathways in Breast Cancer Treatment

A panelist discusses how differences in HER2-positive, HER2-low, and HER2-negative status impact clinical decision-making.

Episodes in this series

EP. 1 Navigating HER2 Heterogeneity: Precision Pathways in Breast Cancer Treatment

EP. 1 Navigating HER2 Heterogeneity: Precision Pathways in Breast Cancer Treatment

5 experts in this video

EP. 2 Metastatic Breast Cancer Treatment Guidelines and the Nuances of HER2-Low Disease in Clinical Practice

5 experts in this video

EP. 3 Transforming Breast Cancer Treatment Through ADC-Targeting Mechanisms

5 experts in this video

EP. 4 How ADC Design Influences Efficacy and Safety

5 experts in this video

EP. 5 Beyond HER2: Expanding the Biomarker Testing Landscape in Metastatic Breast Cancer

5 experts in this video

EP. 6 Comparing Approved ADC Options in HER2-Negative and HER2-Low Breast Cancer

5 experts in this video

EP. 7 Key Considerations for Oncology Pharmacists When Selecting and Sequencing ADC Therapies

5 experts in this video

EP. 8 Emerging ADC Clinical Trial Evidence in Breast Cancer Treatment

5 experts in this video

EP. 9 Personalizing ADC Therapy in mBC Based on Patient Characteristics and Prior Therapies

5 experts in this video

EP. 10 Practical Insights for Pharmacists on ADC Administration, Patient Experience, and Supportive Care

5 experts in this video

EP. 11 Managing ADC Toxicities and Infusion Reactions With Supportive Care Strategies

5 experts in this video

EP. 12 Monitoring Strategies for Managing ADC Toxicities in mBC

5 experts in this video

EP. 13 Optimizing ADC Supportive Care Prescribing and AE Management With Institutional Workflows

5 experts in this video

EP. 14 Discussing ADC Risks, Benefits, and Regimens With Patients

5 experts in this video

EP. 15 Interdisciplinary Approaches to Breast Cancer Care and ADC Treatment Barriers Due to Social Determinants of Health

5 experts in this video

EP. 16 Concluding Remarks: Collaborative Expertise in an Era of Emerging Cancer Therapies

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Content

Trending on Pharmacy Times

Interview with Sa'ed al-Olimat, PharmD: How Pharmacists are Shaping the Future of Psychedelic Therapy

December 2025 Product Updates

A Healthy Gut Could Improve Mental Health

FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia

Reimagining Pharmacy: A Call to Action for Pharmacy Professionals